Prime Medicine PRME EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Prime Medicine’s reported figures.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's EBITDA?
- Prime Medicine (PRME) reported EBITDA of -$48.8M in Q1 2026.
- How has Prime Medicine's EBITDA changed year-over-year?
- Prime Medicine's EBITDA increased by 3.7% year-over-year, from -$50.69M to -$48.8M.
- What is the long-term trend for Prime Medicine's EBITDA?
- Over 3 years (2022 to 2025), Prime Medicine's EBITDA has grown at a 20.7% compound annual growth rate (CAGR), from -$114.32M to -$201.03M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.